These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3258406)

  • 1. Mutations in human lymphocytes studied by an HLA selection system.
    Janatipour M; Trainor KJ; Kutlaca R; Bennett G; Hay J; Turner DR; Morley AA
    Mutat Res; 1988 Mar; 198(1):221-6. PubMed ID: 3258406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of natural killer cells in negative selection of mutant lymphocytes that fail to express the human leukocyte antigen-A2 allele.
    Kusunoki Y; Kyoizumi S; Kubo Y; Hayashi T; MacPhee DG
    Mutat Res; 2001 May; 476(1-2):123-32. PubMed ID: 11336989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in human lymphocytes commonly involve gene duplication and resemble those seen in cancer cels.
    Turner DR; Grist SA; Janatipour M; Morley AA
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3189-92. PubMed ID: 3258992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HLA-AW24 gene: sequence, surroundings and comparison with the HLA-A2 and HLA-A3 genes.
    N'Guyen C; Sodoyer R; Trucy J; Strachan T; Jordan BR
    Immunogenetics; 1985; 21(5):479-89. PubMed ID: 2987115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and molecular characterization of spontaneous mutants of lymphoblastoid cells with extended loss of heterozygosity.
    de Nooij-van Dalen AG; van Buuren-van Seggelen VH; Mulder A; Gelsthorpe K; Cole J; Lohman PH; Giphart-Gassler M
    Mutat Res; 1997 Mar; 374(1):51-62. PubMed ID: 9067415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular nature of in vivo mutations in human cells at the autosomal HLA-A locus.
    Morley AA; Grist SA; Turner DR; Kutlaca A; Bennett G
    Cancer Res; 1990 Aug; 50(15):4584-7. PubMed ID: 2369733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid genes between HLA-A2 and HLA-A3 constructed by in vivo recombination allow mapping of HLA-A2 and HLA-A3 polymorphic antigenic determinants.
    Sire J; Chimini G; Boretto J; Toubert A; Kahn-Perles B; Layet C; Sodoyer R; Lemonnier F; Jordan B
    J Immunol; 1988 Apr; 140(7):2422-30. PubMed ID: 2450922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human somatic mutation at the autosomal HLA-A locus.
    Turner DR; Morley AA
    Prog Clin Biol Res; 1990; 340C():37-46. PubMed ID: 2381935
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrinsic genetic instability of normal human lymphocytes and its implication for loss of heterozygosity.
    de Nooij-Van Dalen AG; Morolli B; van der Keur M; van der Marel A; Lohman PH; Giphart-Gassler M
    Genes Chromosomes Cancer; 2001 Apr; 30(4):323-35. PubMed ID: 11241785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.
    Yang S; Kittlesen D; Slingluff CL; Vervaert CE; Seigler HF; Darrow TL
    J Immunol; 2000 Apr; 164(8):4204-11. PubMed ID: 10754316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HLA-A mutation assay: improved technique and normal results.
    McCarron MA; Kutlaca A; Morley AA
    Mutat Res; 1989 Apr; 225(4):189-93. PubMed ID: 2927440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
    Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
    J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo human somatic mutation: frequency and spectrum with age.
    Grist SA; McCarron M; Kutlaca A; Turner DR; Morley AA
    Mutat Res; 1992 Apr; 266(2):189-96. PubMed ID: 1373828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a flow-cytometric HLA-A locus mutation assay for human peripheral blood lymphocytes.
    Kushiro J; Hirai Y; Kusunoki Y; Kyoizumi S; Kodama Y; Wakisaka A; Jeffreys A; Cologne JB; Dohi K; Nakamura N
    Mutat Res; 1992 Aug; 272(1):17-29. PubMed ID: 1380116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I noninherited maternal antigens in cord blood and breast milk.
    Molitor ML; Haynes LD; Jankowska-Gan E; Mulder A; Burlingham WJ
    Hum Immunol; 2004 Mar; 65(3):231-9. PubMed ID: 15041161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level.
    Koller BH; Orr HT
    J Immunol; 1985 Apr; 134(4):2727-33. PubMed ID: 2982951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon.
    Zemmour J; Little AM; Schendel DJ; Parham P
    J Immunol; 1992 Mar; 148(6):1941-8. PubMed ID: 1541831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unlikely rare result of HLA-A*0236, *3601 masking the presence of a novel allele A*0114.
    Crowley J; Dunne C; Cox ST; Little AM
    Tissue Antigens; 2007 Feb; 69(2):200-1. PubMed ID: 17257324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative structural analysis of HLA-A3 antigens distinguishable by cytotoxic T lymphocytes: variant E1.
    van Schravendijk MR; Biddison WE; Berger AE; Coligan JE
    J Immunol; 1985 Jan; 134(1):410-6. PubMed ID: 3871112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells.
    Jantscheff P; Spagnoli G; Zajac P; Rochlitz CF
    Cancer Immunol Immunother; 2002 Sep; 51(7):367-75. PubMed ID: 12192536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.